Urinary excretion of the vitronectin receptor (integrin α(V)β3) in patients with Fabry disease

Clinica Chimica Acta

Volumn 279, Issue 1-2, 1999, Pages 55-68

  Utsumi, Kouichi ^a   Itoh, Kohji ^a   Kase, Ryoichi ^a   Shimmoto, Michie ^a   Yamamoto, Naomasa ^a   Katagiri, Yasuhiro ^a   Tanoue, Kenjiro ^a   Kotani, Masaharu ^a   Ozawa, Takashi ^b   Oguchi, Tomomasa ^c   Sakuraba, Hitoshi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fabry disease; Globotriaosylceramide; Vitronectin; Vitronectin receptor

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; VITRONECTIN; VITRONECTIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FABRY DISEASE; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY INJURY; MALE; PATHOGENESIS; PRIORITY JOURNAL; URINALYSIS;

ADOLESCENT; ADULT; CHILD; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FABRY DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOBLOTTING; KIDNEY DISEASES; MALE; MIDDLE AGED; RECEPTORS, VITRONECTIN; VITRONECTIN;

EID: 0032955502     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00169-7     Document Type: Article

References (28)

1. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995:2741-84.
2. Adler SG, Cohen AH, Glassock RJ. Secondary glomerular diseases. In: Brenner BM, editor. The kidney. 5th ed. Philadelphia: W.B. Saunders, 1996:1558-59.
3. Fukushima M., Tsuchiyama Y., Nakato T.et al. A female heterozygous patient of Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am. J. Kidney Dis. 26:1995;952-955.
4. Sakuraba H., Oshima A., Fukuhara Y.et al. Identification of point mutations in the α-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am. J. Hum. Genet. 47:1990;784-789.
5. Nakao S., Takenaka T., Maeda M.et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. New. Engl. J. Med. 333:1995;288-293.
6. Kawamura O., Sakuraba H., Itoh K.et al. Subclinical Fabry's disease occurring in the context of IgA nephropathy. Clin. Nephrol. 47:1997;71-75.
7. Ruoslahti E. Integrins. J. Clin. Invest. 87:1991;1-5.
8. Madri J.A., Basson M.D. Extracellular matrix-cell interactions. Dynamic modulations of cell, tissue and organism structure and function. Lab. Invest. 66:1991;519-521.
9. Adler S. Integrin matrix receptors in renal injury. Kidney Int. 45(suppl 45):1994;86-89.
10. Ruoslahti E., Noble N.A., Kagami S., Border W.A. Integrins. Kidney Int. 45(suppl 44):1994;17-22.
11. Kotani M., Yamamura Y., Tamatani T., Kitamura F., Miyasaka M. Generation and characterization of monoclonal antibodies against rabbit CD4, CD5 and CD11a antigens. J. Immunol. Methods. 157:1993;241-252.
12. Katayama M., Kurome T., Yamamoto K., Uchida H., Hino F., Kato I. Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies. Clin. Chim. Acta. 202:1991;179-190.
13. Shikata K., Makino H., Morioka S.et al. Distribution of extracellular matrix receptors in various forms of glomerulonephritis. Am. J. Kidney Dis. 25:1995;680-688.
14. Izumi M., Shimo-Oka T., Morishita N., Ii I., Hayashi M. Identification of the collagen-binding domain of vitronectin using monoclonal antibodies. Cell Struct. Funct. 13:1988;217-225.
15. Hayman E.G., Pierschbacher M.D., Ohgren Y., Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc. Natl. Acad. Sci. U.S.A. 80:1983;4003-4007.
16. Kotani M., Kawashima I., Ozawa H., Ogura K., Ariga T., Tai T. Generation of one set of murine monoclonal antibodies specific for globo-series glycolipid: Evidence for differential distribution of the glycolipid in rat small intestine. Arch. Biochem. Biophys. 310:1994;89-96.
17. Itoh K., Kotani M., Tai T.et al. Immunofluorescence imaging diagnosis of Fabry heterozygotes using confocal laser scanning microscopy. Clin. Genet. 44:1993;302-306.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
19. Fossati P., Prencipe L., Berti G. Enzymic creatinine assay: A new colorimetric method based on hydrogen peroxide measurement. Clin. Chem. 29:1983;1494-1496.
20. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
21. Kleinbaum DG, Kupper CL, Muller KF. Applied regression analysis and other multivariable methods. Boston: PWS-Kent, 1988.
22. Ogawa T., Yorioka N., Yamakido M. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy. Nephron. 68:1994;87-96.
23. Okada M., Yoshioka K., Takemura T.et al. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor. Virchows Arch. A Pathol. Anat. Histopathol. 422:1993;367-373.
24. 3 integrins in human fetal and adult kidney. Lav. Invest. 62:1990;616-625.
25. Lyon M.F. Sex chromatin and gene action in the mammalian X-chromosome. Am. J. Hum. Genet. 14:1962;135-148.
26. Kanahara K., Yorioka N., Arita M., Ohira N., Yamakido M. Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy. Nephron. 66:1994;29-37.
27. Kerjaschki D. The pathogenesis of membranous glomerulonephritis from morphology to molecules. Virchows Arch. B Cell Pathol. 58:1990;253-271.
28. Floege J., Johnson R.J., Gordon K.et al. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 40:1991;477-488.